Next Healthcare Forum: Roberta Lipson

I’ve mentioned before that there is a new Beijing Healthcare Forum which meets bimonthly at Luce. Here’s our description from the Google group website:

We are a group of academics and professionals engaged in projects and enterprises related to health care services.  Our goal is to better inform ourselves and others about emerging trends in the Chinese health care system and market while expanding our network of professional contacts and resources.

Everyone is invited to attend our free Thursday sessions, and this Thurday, November 19 we have the pleasure of listening to Beijing’s well known Roberta Lipson. Here’s more information:

Roberta Lipson, CEO of Chindex (owner of the United Family Hospital group and seller of medical equipment, instrumentation, and products), will be the next speaker at our bi-monthly healthcare group.  We really want to make sure we have a good showing to hear her speak because she has tremendous insight into the Chinese healthcare market, is a terrific speaker, and is an all around wonderful person.  She’s been in China since 1979 and has been the CEO of Chindex since 1981.  Prior to starting Chindex, she worked with Schering-Plough, a pharmaceutical company, and with Sobin Chemical, a worldwide trading company.  As a business leader, managing a multi-hundred-million dollar enterprise, Roberta has powerful things to say about the future of the Chinese healthcare industry.  We think anyone interested in healthcare in China, or China in general, would want to come.

If you know of anyone who would be interested in coming to hear her speak, you should definitely let them know.  Below are the details for the meeting.
Meeting Details:
Date: Thursday, November 19th
Time: 8:00PM (Discussion to start at 8:45PM.)
Where: Luce Restaurant
Address: 138 Jiugulou Dajie, Dongcheng District, Beijing

Follow me on:
Twitter @RichardStCyrMD
Facebook @BainbridgeBabaDoc
Photography: richardsaintcyr.com

One thought on “Next Healthcare Forum: Roberta Lipson”

Leave a Reply